Biotech · Private company
Curium US LLC
Track this companyFree. Adds Curium US LLC to your Dealase workspace and tells you when its record changes.
Clinical trials64 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 177Lu-PSMA-I&TPhase 3 · Metastasis From Malignant Tumor of ProstateClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone with Prednisone or EnzalutamidePhase 3 · Metastasis From Malignant Tumor of ProstateClinicalTrials.gov · fetched Nov 12, 2026
- Copper Cu 64 PSMA I&TPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- 64Cu-PSMA I&TPhase 2 · Metastasis From Malignant Tumor of Prostate (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine NeoplasmsPHASE3 · RECRUITING · started Nov 2, 2026ClinicalTrials.gov NCT07842172 · fetched Nov 12, 2026
- Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATEPHASE4 · RECRUITING · started Sep 11, 2024ClinicalTrials.gov NCT06377371 · fetched Nov 12, 2026
- Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 1, 2024ClinicalTrials.gov NCT06235151 · fetched Nov 12, 2026
- Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate CancerPHASE3 · COMPLETED · started Apr 1, 2024ClinicalTrials.gov NCT06235099 · fetched Nov 12, 2026
- Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate CancerPHASE2 · COMPLETED · started Dec 5, 2022ClinicalTrials.gov NCT05653856 · fetched Nov 12, 2026
- 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 14, 2022ClinicalTrials.gov NCT05204927 · fetched Nov 12, 2026